175 related articles for article (PubMed ID: 29515234)
21. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
22. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
[TBL] [Abstract][Full Text] [Related]
23. Function and regulation of the mono-ADP-ribosyltransferase ARTD10.
Kaufmann M; Feijs KL; Lüscher B
Curr Top Microbiol Immunol; 2015; 384():167-88. PubMed ID: 24878761
[TBL] [Abstract][Full Text] [Related]
24. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
26. Rational Design of Cell-Active Inhibitors of PARP10.
Morgan RK; Kirby IT; Vermehren-Schmaedick A; Rodriguez K; Cohen MS
ACS Med Chem Lett; 2019 Jan; 10(1):74-79. PubMed ID: 30655950
[TBL] [Abstract][Full Text] [Related]
27. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
28. PARP10 promotes cellular proliferation and tumorigenesis by alleviating replication stress.
Schleicher EM; Galvan AM; Imamura-Kawasawa Y; Moldovan GL; Nicolae CM
Nucleic Acids Res; 2018 Sep; 46(17):8908-8916. PubMed ID: 30032250
[TBL] [Abstract][Full Text] [Related]
29. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
31. AQP5 promotes hepatocellular carcinoma metastasis via NF-κB-regulated epithelial-mesenchymal transition.
He Z; Dong W; Hu J; Ren X
Biochem Biophys Res Commun; 2017 Aug; 490(2):343-348. PubMed ID: 28619511
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of 3- and 4-Phenoxybenzamides as Selective Inhibitors of the Mono-ADP-Ribosyltransferase PARP10.
Korn P; Classen A; Murthy S; Guareschi R; Maksimainen MM; Lippok BE; Galera-Prat A; Sowa ST; Voigt C; Rossetti G; Lehtiö L; Bolm C; Lüscher B
ChemistryOpen; 2021 Oct; 10(10):939-948. PubMed ID: 34145784
[TBL] [Abstract][Full Text] [Related]
33. Discs large homolog 5 decreases formation and function of invadopodia in human hepatocellular carcinoma via Girdin and Tks5.
Ke Y; Bao T; Zhou Q; Wang Y; Ge J; Fu B; Wu X; Tang H; Shi Z; Lei X; Zhang C; Tan Y; Chen H; Guo Z; Wang L
Int J Cancer; 2017 Jul; 141(2):364-376. PubMed ID: 28390157
[TBL] [Abstract][Full Text] [Related]
34. Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.
Wang C; Jiang K; Kang X; Gao D; Sun C; Li Y; Sun L; Zhang S; Liu X; Wu W; Yang P; Guo K; Liu Y
Int J Biochem Cell Biol; 2012 Dec; 44(12):2308-20. PubMed ID: 23010347
[TBL] [Abstract][Full Text] [Related]
35. Activity-based assay for human mono-ADP-ribosyltransferases ARTD7/PARP15 and ARTD10/PARP10 aimed at screening and profiling inhibitors.
Venkannagari H; Fallarero A; Feijs KL; Lüscher B; Lehtiö L
Eur J Pharm Sci; 2013 May; 49(2):148-56. PubMed ID: 23485441
[TBL] [Abstract][Full Text] [Related]
36. Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15.
Nizi MG; Maksimainen MM; Murthy S; Massari S; Alaviuhkola J; Lippok BE; Sowa ST; Galera-Prat A; Prunskaite-Hyyryläinen R; Lüscher B; Korn P; Lehtiö L; Tabarrini O
Eur J Med Chem; 2022 Jul; 237():114362. PubMed ID: 35500474
[TBL] [Abstract][Full Text] [Related]
37. Analogs of TIQ-A as inhibitors of human mono-ADP-ribosylating PARPs.
Maksimainen MM; Murthy S; Sowa ST; Galera-Prat A; Rolina E; Heiskanen JP; Lehtiö L
Bioorg Med Chem; 2021 Dec; 52():116511. PubMed ID: 34801828
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
39. HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma.
Wang X; Dong J; Jia L; Zhao T; Lang M; Li Z; Lan C; Li X; Hao J; Wang H; Qin T; Huang C; Yang S; Yu M; Ren H
Cancer Lett; 2017 May; 393():113-124. PubMed ID: 28153790
[TBL] [Abstract][Full Text] [Related]
40. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
